<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Anaerobic bacterial infections
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Anaerobic bacterial infections
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Anaerobic bacterial infections
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Cynthia L Sears, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen B Calderwood, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Milana Bogorodskaya, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 14, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria are the predominant cultivable and noncultivable bacteria in the human body and can be recovered from infections at virtually all anatomic sites, although the frequency of recovery is highly variable. This topic will focus on the microbiology, pathogenesis, sites of infection, diagnosis, and management of obligate anaerobic flora that are endogenous to the host.
        </p>
        <p>
         Actinomycosis is discussed separately (see
         <a class="medical medical_review" href="/z/d/html/3411.html" rel="external">
          "Cervicofacial actinomycosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2691.html" rel="external">
          "Abdominal actinomycosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13997.html" rel="external">
          "Treatment of actinomycosis"
         </a>
         ). Toxin-mediated and/or tissue destructive clostridial infections are reviewed separately by individual pathogen and/or syndrome (eg, tetanus, botulism,
         <em>
          Clostridioides
         </em>
         [formerly
         <em>
          Clostridium
         </em>
         ]
         <em>
          difficile
         </em>
         infection, gas gangrene, neutropenic enterocolitis due to
         <em>
          Clostridium septicum
         </em>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5525.html" rel="external">
          "Tetanus"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5509.html" rel="external">
          "Botulism"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2696.html" rel="external">
          "
          <i>
           Clostridioides difficile
          </i>
          infection in adults: Epidemiology, microbiology, and pathophysiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7672.html" rel="external">
          "Clostridial myonecrosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5539.html" rel="external">
          "Toxic shock syndrome due to Paeniclostridium sordellii"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2690.html" rel="external">
          "Neutropenic enterocolitis (typhlitis)"
         </a>
         .)
        </p>
        <p>
         Fusobacteria are reviewed separately by syndrome (eg, Lemierre syndrome, Ludwig angina, deep neck space infections, liver abscess). (See
         <a class="medical medical_review" href="/z/d/html/129255.html" rel="external">
          "Lemierre syndrome: Septic thrombophlebitis of the internal jugular vein"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3415.html" rel="external">
          "Deep neck space infections in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3417.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13964.html" rel="external">
          "Ludwig angina"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2680.html" rel="external">
          "Pyogenic liver abscess"
         </a>
         .)
        </p>
        <p>
         Discussion of microbiome and the host-pathogen relationship in the gastrointestinal tract is found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2556.html" rel="external">
          "Spatial organization of intestinal microbiota in health and disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H871415634">
         <span class="h1">
          MICROBIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H1740521049">
         <span class="h2">
          Definition
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria are defined as bacteria that require reduced oxygen tension for growth. These bacteria fail to show surface (colony) growth in 10 percent carbon dioxide (eg, a microaerophilic environment that supports
         <em>
          Campylobacter
         </em>
         spp growth) or in air (18 percent oxygen) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1674918999">
         <span class="h2">
          Classification by aerotolerance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobes may be classified by their relative aerotolerance.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Obligate (strict) anaerobes
         </strong>
         − Obligate anaerobes are rapidly killed by oxygen and grow in the complete absence of oxygen. The anaerobic genera
         <em>
          Bacteroides
         </em>
         spp,
         <em>
          Fusobacterium
         </em>
         spp,
         <em>
          Prevotella
         </em>
         spp, gram-positive anaerobic cocci, and most
         <em>
          Clostridia
         </em>
         spp are considered obligately anaerobic. Even strict anaerobes may survive, but usually not grow, in small amounts of oxygen (eg, nanomolar levels) as seen with
         <em>
          B
         </em>
         .
         <em>
          fragilis
         </em>
         [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aerotolerant anaerobes
         </strong>
         − Aerotolerance among anaerobes varies by species with some species tolerating up to 8 percent oxygen [
         <a href="#rid1">
          1
         </a>
         ]. While some of these organisms survive in air, they do not replicate and are metabolically inactive in this state. Examples of clinically important aerotolerant anaerobes are some
         <em>
          Clostridia
         </em>
         spp,
         <em>
         </em>
         and most
         <em>
          Cutibacterium
         </em>
         spp (eg, including
         <em>
          Cutibacterium acnes
         </em>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H705994787">
         <span class="h2">
          Identification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria are fastidious organisms that can be difficult to grow in clinical microbiology laboratories. These organisms require low-oxygen conditions for growth and most grow slowly in complex communities. In these communities, pathogenic anaerobic bacteria most often coexist with commensal or symbiotic anaerobic bacteria, further hindering identification of potential anaerobic pathogens from complex specimens (eg, stool, abscesses). (See
         <a class="local">
          'Microbiologic diagnosis'
         </a>
         below.)
        </p>
        <p>
         While most clinical laboratories can identify the major clinically significant anaerobes (eg,
         <em>
          Clostridium
         </em>
         spp,
         <em>
          Bacteroides
         </em>
         spp,
         <em>
          Fusobacterium
         </em>
         spp,
         <em>
          Peptostreptococcus
         </em>
         spp,
         <em>
          Cutibacterium
         </em>
         spp), growing and identifying the majority of colonizing anaerobic bacteria is challenging using laboratory methods. As an example, in an analysis of 13,555 prokaryotic ribosomal RNA gene sequences from the colon, most bacteria were considered novel, uncultivated micro-organisms [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1479259967">
         <span class="h2">
          Clinically significant anaerobes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The major clinically significant anaerobes are summarized in the table  (
         <a class="graphic graphic_table graphicRef61844" href="/z/d/graphic/61844.html" rel="external">
          table 1
         </a>
         ). Most clinical laboratories should be able to identify these organisms. Clinically significant anaerobes can be divided into gram-negative bacilli, spore-forming and non-spore-forming gram-positive bacilli, and gram-positive or gram-negative cocci.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gram-negative bacilli
         </strong>
         – Important gram-negative anaerobes for identification include the
         <em>
          Bacteroides
         </em>
         spp,
         <em>
          Prevotella
         </em>
         spp, and
         <em>
          Fusobacterium
         </em>
         spp.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          <em>
           Bacteroides
          </em>
         </strong>
         <strong>
          spp
         </strong>
         –
         <em>
          Bacteroides
         </em>
         spp are small, pleomorphic gram-negative bacilli. Among the more than 50 known
         <em>
          Bacteroides
         </em>
         spp [
         <a href="#rid4">
          4
         </a>
         ],
         <em>
          B. fragilis
         </em>
         is the most important in human disease. Other
         <em>
          Bacteroides
         </em>
         spp, previously designated with
         <em>
          B. fragilis
         </em>
         as the '
         <em>
          B. fragilis
         </em>
         group' (ie,
         <em>
          B. thetaiotaomicron, B. distasonis, B. ovatus, and B. vulgatus
         </em>
         ), also contribute to human disease.
         <em>
          Bacteroides
         </em>
         spp are distinguished by their ability to grow in the presence of 20 percent bile.
         <em>
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <em>
          B. fragilis
         </em>
         is a uniquely virulent anaerobe. The organism typically constitutes only 0.5 percent or less of cultivable normal colonic flora, yet it is the most common anaerobe isolated from intra-abdominal infections and is the most frequent anaerobic isolate in cases of bacteremia [
         <a href="#rid5">
          5-7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          <em>
           Prevotella
          </em>
         </strong>
         <strong>
          spp
         </strong>
         – Pigmented
         <em>
          Prevotella
         </em>
         (eg,
         <em>
          P. melaninogenica
         </em>
         ,
         <em>
          P. corporis
         </em>
         ,
         <em>
          P. intermedia
         </em>
         ,
         <em>
          P. loescheii
         </em>
         , and
         <em>
          P. nigrescens
         </em>
         ) are a clinically important group of fastidious anaerobes. The frequency of recovery of these species depends upon the expertise of the laboratory. Other pigmented anaerobic bacteria include species from the genera
         <em>
          Porphyromonas
         </em>
         spp and
         <em>
          Alistipes
         </em>
         spp.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          <em>
           Fusobacterium
          </em>
         </strong>
         <strong>
          spp
         </strong>
         – Fusobacteria are fastidious organisms that can be distinguished from
         <em>
          Bacteroides
         </em>
         spp because they are usually indole positive and nonmotile and show distinctive morphologic features on Gram stain (typically slender, elongated gram-negative rods but can be gram-variable as well as variable in morphology).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Spore-forming gram-positive bacilli
         </strong>
         – Spore-forming gram-positive bacilli includes
         <em>
          Clostridium
         </em>
         spp and
         <em>
          Clostridioides
         </em>
         <em>
          difficile
         </em>
         . The species are heterogenous and are known for their toxin-producing properties and difficult to eradicate spores that are visible on Gram stains.
         <em>
          Clostridia
         </em>
         spores enable the organism to survive exposure to ethanol for 30 minutes or heating to 80°C for 10 minutes. Extensive biochemical testing is required for speciation, which generally is unnecessary except in selected cases, such as gas gangrene.
         <em>
          C. difficile
         </em>
         may be cultured from stool, but antigen assays, toxin assays, and polymerase chain reaction are more practical.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Non-spore-forming gram-positive bacilli
         </strong>
         – The non-spore-forming gram-positive bacilli group includes genera from the phyla Actinobacteria and Firmicutes. Actinobacteria genera of clinical relevance include
         <em>
          Actinomyces
         </em>
         spp,
         <em>
          Cutibacterium
         </em>
         spp (formerly
         <em>
          Propionibacterium
         </em>
         ), and
         <em>
          Eggerthella
         </em>
         spp [
         <a href="#rid8">
          8
         </a>
         ]; Firmicutes genera include
         <em>
          Faecalibacterium
         </em>
         spp and
         <em>
          Lactobacillus
         </em>
         spp among others. This complex group of bacteria is most often identified by DNA sequencing analysis and/or matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). With the exception of
         <em>
          Actinomyces
         </em>
         spp, most of these organisms have limited documented pathogenic potential. While
         <em>
          Cutibacterium
         </em>
         spp is usually a contaminant in clinical samples, this bacterium can play an important role in septic arthritis complicating shoulder prostheses, infections following neurosurgery, and other device-related infections [
         <a href="#rid9">
          9
         </a>
         ]. Actinomyces is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3411.html" rel="external">
          "Cervicofacial actinomycosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2691.html" rel="external">
          "Abdominal actinomycosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13997.html" rel="external">
          "Treatment of actinomycosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gram-positive cocci
         </strong>
         – The key clinically relevant anaerobic gram-positive cocci are
         <em>
          Peptostreptococcus
         </em>
         spp. The species rarely merits speciation because these organisms lack distinctive virulence properties and appear to be predictably susceptible to antimicrobial agents.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gram-negative cocci
         </strong>
         –
         <em>
          Veillonella
         </em>
         species (eg,
         <em>
          Veillonella parvula
         </em>
         ) are common anaerobic members of the oral flora.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1475951482">
         <span class="h2">
          Susceptibility testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic culture results with susceptibility testing are often labor intensive, time consuming, expensive, incomplete, and generally not available in a clinically relevant time frame. Thus, antibiotic decisions for anaerobic pathogens are often best made based upon predicted susceptibility patterns according to the Gram stain, the anatomic site of infection, and available published survey data for specific anaerobes [
         <a href="#rid10">
          10-12
         </a>
         ].
        </p>
        <p>
         Based on these practical issues, the Clinical and Laboratory Standards Institute (CLSI) Working Group on Anaerobic Susceptibility Testing and the Manual of Clinical Microbiology provide guidance on anaerobe susceptibility testing [
         <a href="#rid12">
          12,13
         </a>
         ]. The following settings are clinical situations in which anaerobic susceptibility testing may be reasonable for anaerobes considered pathogenic.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To monitor local and regional resistance patterns
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To test new antimicrobial agents
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To select antibiotics that are critical for individual patient management because of:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Critical illness
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Known resistance of an organism or species
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Persistent infection despite appropriate antibiotics
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Anticipated pivotal role of the selected antimicrobial agent in therapy (eg, osteomyelitis, joint space infections)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         To confirm antimicrobial activity when long courses of antibiotics are required
        </p>
        <p>
        </p>
        <p>
         Most clinical laboratories will not perform anaerobe susceptibility tests unless they are specifically requested. Because anaerobes are slow growing, results are usually available only after therapeutic decisions have already been made.
        </p>
        <p class="headingAnchor" id="H971790453">
         <span class="h1">
          ROLE IN THE HUMAN MICROBIOME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria are major constituents of the human microbiome at virtually all anatomic sites. Viruses, fungi, and parasites are also microbiome members although their contributions to human health and microbiome function remain less well studied and understood. Most mucocutaneous surfaces of humans harbor a rich indigenous flora composed of aerobic and anaerobic bacteria, with microbial species and concentrations varying at different anatomic sites.
        </p>
        <p>
         The assembly of the human microbiome begins at birth and is impacted by mode of birth. It appears that even these very early facets of microbiome assembly are linked to disease onset in children [
         <a href="#rid14">
          14
         </a>
         ]. Most studies have explored the makeup of human colonic bacterial microbiota. The colon accounts for the greatest abundance of human anaerobic bacteria (500 to 1000 species per individual) [
         <a href="#rid3">
          3
         </a>
         ]. The colon microbiome functions to maintain health by establishing ecologic balance, assisting with nutrition, and preventing colonization with exogenous organisms including potential human disease pathogens ('colonization resistance'). There is substantial individual variation that is strongly influenced by diet and medications (especially antibiotics) with less impact by host genetic make-up [
         <a href="#rid3">
          3,15,16
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2556.html" rel="external">
          "Spatial organization of intestinal microbiota in health and disease"
         </a>
         .)
        </p>
        <p>
         Any oral antibiotic exposure disrupts the colon microbiome and longer term effects of repeated antibiotic exposure on disease are under study [
         <a href="#rid17">
          17,18
         </a>
         ]. For example, oral antibiotics decrease the 'colonization resistance' provided by a diverse colon microbiota, which enhances the potential for infection with enteric pathogens and colonization by resistant bacteria, such as vancomycin-resistant enterococci, and resistant gram-negative bacilli. These bacteria cause many nosocomial infections, including serious infections in patients with neutropenia, organ transplantation, or critical illness. Disruption of the colon microbiome is critical to precipitating
         <em>
          C. difficile
         </em>
         infection and linked, for example, to outcomes in bone marrow transplantation [
         <a href="#rid19">
          19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16708.html" rel="external">
          "Overview of neutropenic fever syndromes"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3810.html" rel="external">
          "Nosocomial infections in the intensive care unit: Epidemiology and prevention"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2699.html" rel="external">
          "
          <i>
           Clostridioides difficile
          </i>
          infection in adults: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         While extensive work seeks to identify approaches to modify the microbiome to impact either acute or chronic disease, only limited approaches are available for clinical use, namely, fecal microbiota transplantation (FMT), most often used for treatment of recurrent
         <em>
          C. difficile
         </em>
         colitis, as well as FDA-approved fecal microbiota products for prevention of recurrent
         <em>
          C. difficile
         </em>
         colitis [
         <a href="#rid20">
          20,21
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16307.html" rel="external">
          "Overview of possible risk factors for cardiovascular disease", section on 'Trimethylamine-N-oxide'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2603.html" rel="external">
          "Probiotics for gastrointestinal diseases", section on 'Irritable bowel syndrome'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2604.html" rel="external">
          "Fecal microbiota transplantation for treatment of
          <i>
           Clostridioides difficile
          </i>
          infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1085112959">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic infections nearly always arise from spillage and/or invasion of endogenous bacteria into contiguous sites of the body but also spread systemically (eg, bacteremia). The usual pathophysiologic mechanism for anaerobic infection is a breach in the mucocutaneous barrier (eg, bowel perforation, carcinoma with obstruction, mucositis, perirectal lesions, or compromised consciousness with aspiration) resulting in displacement of the resident flora.
        </p>
        <p>
         Important exceptions are toxin-mediated syndromes such as clostridial syndromes, including botulism,
         <em>
          Clostridium perfringens
         </em>
         food poisoning, enteritis necroticans, tetanus, some cases of gas gangrene, and
         <em>
          Clostridioides
         </em>
         <em>
          difficile-
         </em>
         associated diarrhea.
        </p>
        <p>
         The following are major factors implicated in the pathogenesis of anaerobic infections:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Production of toxins
         </strong>
         — The most clearly identified virulence factors for anaerobic bacteria are the exotoxins produced by clostridial species, including botulinum toxins, tetanus toxin,
         <em>
          C. difficile
         </em>
         toxin B, and the &gt;20 toxins produced by
         <em>
          C. perfringens
         </em>
         (as well as many other clostridial species) [
         <a href="#rid22">
          22-24
         </a>
         ]. Clostridial species have also been shown to produce leukocytosis-inducing factors that result in marked leukocytosis in some infected patients ("leukemoid reaction") [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A molecular subgroup
         <em>
          of Bacteroides fragilis
         </em>
         secrete a pro-inflammatory metalloprotease enterotoxin [
         <a href="#rid26">
          26
         </a>
         ]. Strains producing the toxin are associated with self-limited diarrheal illnesses in children and adults and not uncommonly asymptomatically colonize healthy individuals. There is evidence from mouse models and human studies that enterotoxin-producing strains
         <em>
          of B. fragilis
         </em>
         may play a role in colon carcinoma [
         <a href="#rid27">
          27-29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role of capsular polysaccharides in abscess formation
         </strong>
         — Capsular polysaccharide complexes have zwitterionic properties (presenting oppositely charged atoms) that are important for abscess formation [
         <a href="#rid30">
          30,31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Presence of lipopolysaccharides
         </strong>
         — Anaerobic gram-negative bacteria, like all gram-negative bacteria, contain lipopolysaccharide (LPS) that can be extracted from the cell envelope. LPS from anaerobic bacteria can differ structurally from LPS from aerobic gram-negative bacteria and may display lower biologic activity [
         <a href="#rid32">
          32
         </a>
         ]. The endotoxin of Fusobacteria is postulated to account, at least in part, for the severity of illness associated with Lemierre disease [
         <a href="#rid33">
          33,34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ability to tolerate oxygen
         </strong>
         — Some anaerobic bacteria, such as the virulent
         <em>
          B. fragilis
         </em>
         , can tolerate exposure to oxygen and even replicate at very low oxygen tensions [
         <a href="#rid35">
          35
         </a>
         ]. The ability to survive exposure to oxygen facilitates the survival and thus pathogenicity of the organism such as in abdominal abscess formation. Furthermore, aerobic bacteria are thought to facilitate the growth of
         <em>
          B. fragilis
         </em>
         and other anaerobes by utilizing the oxygen in the environment [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Production of short chain fatty acids
         </strong>
         — Anaerobes produce short-chain fatty acids that are thought to contribute to intestinal homeostasis with additional systemic effects, often through G-protein-coupled receptors. [
         <a href="#rid37">
          37,38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H262499420">
         <span class="h1">
          SITES OF INFECTION
         </span>
        </p>
        <p class="headingAnchor" id="H1894007749">
         <span class="h2">
          Spectrum of disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobes
         <strong>
         </strong>
         are part of the normal skin, genital, oral, and gastrointestinal tract (especially the colon) flora. Infections often originate from these sites and contiguously spread. Infections range from relatively minor skin and oral infections (eg, pharyngitis and gingivitis) to life-threatening invasive infections (eg, bacteremia, distant focal suppurative metastatic infections involving the brain, deep neck space, or muscle and fascia) [
         <a href="#rid39">
          39-42
         </a>
         ]  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         In many cases, the infections are polymicrobial, involving other microbes present at the tissue site.
        </p>
        <p>
         Presence of an abscess should alert the clinician to the likely presence of anaerobes, as anaerobic infections are frequently associated with abscess formation.
        </p>
        <p>
         Clinical manifestations, diagnosis, and treatment for given infectious syndromes are discussed in relevant UpToDate topics, for which links are provided below.
        </p>
        <p class="headingAnchor" id="H1251923885">
         <span class="h2">
          Infections of the upper airways
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria comprise 90 percent of the oral cavity bacteria [
         <a href="#rid1">
          1
         </a>
         ] and are involved in a variety of infections of the oral cavity and adjacent structures. Organisms isolated in oral infection reflect the normal oral flora. The dominant isolates are
         <em>
          Fusobacterium
         </em>
         spp
         <em>
          , Bacteroides
         </em>
         spp,
         <em>
         </em>
         gram-positive anaerobic cocci
         <em>
         </em>
         (eg,
         <em>
          Peptostreptococci
         </em>
         ),
         <em>
          Veillonella
         </em>
         spp, the pigmented
         <em>
          Prevotella
         </em>
         spp,
         <em>
          Porphyromonas
         </em>
         spp,
         <em>
          Treponema
         </em>
         spp, microaerophilic streptococci, and aerobic streptococci [
         <a href="#rid43">
          43-45
         </a>
         ]  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H661585825">
         <span class="h3">
          Dental infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobes are usually involved in gingivitis, periodontitis, pyorrhea, pulpitis (endodontal infection), periapical or dental abscess, and perimandibular space infections  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). These three latter infections usually represent a continuum: the initial lesion is endodontal, then the infection progresses to the periapical region, and then may extend through the mandible to involve the potential spaces created by fascial insertions along the mandible [
         <a href="#rid46">
          46-48
         </a>
         ]. Odontogenic sinusitis with orbital and intracranial extension is a complication of apical periodontitis [
         <a href="#rid49">
          49
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3417.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections"
         </a>
         .)
        </p>
        <p>
         An infrequent but distinct oral infection is necrotizing ulcerative gingivitis, sometimes known as Vincent angina or trench mouth [
         <a href="#rid47">
          47
         </a>
         ]. This is a fulminant infection associated with severe pain, tissue destruction, pseudomembrane formation, and putrid discharge. The bacterial agent is not well established but
         <em>
          Fusobacteria
         </em>
         spp may contribute and anaerobic spirochetes (eg,
         <em>
          Treponema
         </em>
         spp) have been detected within tissue at the advancing edge of inflammation. Antibiotic treatment directed against anaerobes is necessary. (See
         <a class="medical medical_review" href="/z/d/html/3417.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6858.html" rel="external">
          "Overview of gingivitis and periodontitis in adults"
         </a>
         .)
        </p>
        <p>
         A possibly related necrotizing infection of the oral mucous membranes is noma, also called cancrum oris or orofacial gangrene, which is characterized by destruction of soft tissue and bone. It evolves rapidly from gingival inflammation to orofacial gangrene [
         <a href="#rid50">
          50
         </a>
         ]. Noma occurs most frequently in children (peak incidence at ages 1 to 4 years) with malnutrition or systemic disease, is usually fatal in the absence of antibiotic therapy, and is considered a neglected disease [
         <a href="#rid51">
          51
         </a>
         ]. The microbiology is poorly documented but anaerobic gram-negative rods including
         <em>
          Fusobacteria
         </em>
         spp (eg,
         <em>
          F. necrophorum
         </em>
         and others) are thought to contribute. (See
         <a class="medical medical_review" href="/z/d/html/3037.html" rel="external">
          "Noma (cancrum oris)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4261608972">
         <span class="h3">
          Deep neck space infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Deep neck space infections usually arise from dental infections involving molar teeth and, less commonly, from infections of the pharynx or tonsils. Oral flora (including oral anaerobes) play an important role in these infections, but they may also be caused by
         <em>
          Staphylococcus aureus
         </em>
         and aerobic enteric gram-negative bacilli [
         <a href="#rid52">
          52
         </a>
         ]  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         Clinically important anaerobic infections of the deep neck space include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Peritonsillar abscess
         </strong>
         – Peritonsillar abscess is an example of a deep neck space infection that is frequently caused by anaerobic bacteria, such as
         <em>
          F. necrophorum
         </em>
         and
         <em>
          Peptostreptococcus
         </em>
         spp. (See
         <a class="medical medical_review" href="/z/d/html/6079.html" rel="external">
          "Peritonsillar cellulitis and abscess"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ludwig angina
         </strong>
         – Ludwig angina is an infection characterized by bilateral involvement of the sublingual, submandibular, and submental spaces that causes swelling of the base of the tongue and potential airway compromise, hence "angina." It is typically a polymicrobial infection involving the flora of the oral cavity, including anaerobes [
         <a href="#rid53">
          53
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13964.html" rel="external">
          "Ludwig angina"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lemierre syndrome
         </strong>
         – Lemierre syndrome, or jugular vein suppurative thrombophlebitis, is an infection involving the posterior compartment of the lateral pharyngeal space complicated by suppurative thrombophlebitis of the jugular vein. This life-threatening infection is most often associated with
         <em>
          Fusobacterium necrophorum
         </em>
         bacteremia, with potential for metastatic abscesses, primarily to the lung [
         <a href="#rid54">
          54
         </a>
         ]. Other anaerobic species (eg,
         <em>
          Fusobacterium nucleatum
         </em>
         , streptococci) occasionally are isolated [
         <a href="#rid55">
          55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/129255.html" rel="external">
          "Lemierre syndrome: Septic thrombophlebitis of the internal jugular vein"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Studies have also implicated
         <em>
          F. necrophorum
         </em>
         as a possibly important cause of pharyngitis [
         <a href="#rid56">
          56-58
         </a>
         ]. Deep neck space infections are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3415.html" rel="external">
          "Deep neck space infections in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3750817882">
         <span class="h3">
          Chronic rhinosinusitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria have been implicated with variable frequencies in chronic sinusitis, chronic otitis media, and mastoiditis but play a minimal role in acute otitis media or acute sinusitis  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/3412.html" rel="external">
          "Microbiology and antibiotic management of chronic rhinosinusitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7528.html" rel="external">
          "Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3425447252">
         <span class="h2">
          Pleuropulmonary infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria (mostly from the oral anaerobic flora) are relatively common and frequently overlooked pathogens in the lower airways [
         <a href="#rid44">
          44
         </a>
         ]  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). These infections usually arise from aspiration of oral secretions that result in aspiration pneumonitis. Classically, this is an indolent form of pneumonia, but the early presentation is difficult to distinguish from other forms of acute bacterial pneumonia since the clinical clues indicating an anaerobic infection are typically absent early on. Pathogens in macroaspiration pneumonia depend on the clinical context and can include anaerobes (predominantly oral anaerobes), aerobic bacteria, and nosocomial pathogens [
         <a href="#rid59">
          59,60
         </a>
         ].
        </p>
        <p>
         Although now seen infrequently, clinical clues to chronic anaerobic aspiration pneumonia include a predisposition to aspirate, infection in a dependent pulmonary segment, putrid sputum, and an indolent course. Whereas patients with pneumococcal pneumonia often have the abrupt onset of symptoms accompanied by a shaking chill and a rapid progression of symptoms, these features are rare with an anaerobic pleuropulmonary infection. By contrast, patients with a chronic aspiration pneumonia and/or pulmonary abscess often present with weight loss, anemia, and chronic pulmonary complaints, all features that are relatively uncommon in pneumonia due to most aerobic bacteria other than mycobacteria. Nevertheless, pneumonia due to anaerobic bacteria may simulate pneumococcal pneumonia during the early stages and the clinical clues that lead clinicians to suspect anaerobic infection can be absent [
         <a href="#rid44">
          44,59
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7024.html" rel="external">
          "Aspiration pneumonia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7030.html" rel="external">
          "Lung abscess in adults", section on 'Microbiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6702.html" rel="external">
          "Epidemiology, clinical presentation, and diagnostic evaluation of parapneumonic effusion and empyema in adults", section on 'Bacteria'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H899103373">
         <span class="h2">
          Intra-abdominal infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic infections within the abdominal cavity are usually polymicrobial and result in intra-abdominal abscess or secondary peritonitis, which may be generalized or localized (phlegmon).
        </p>
        <p>
         Organisms isolated in intra-abdominal infections typically reflect normal colon flora. The stomach is protected by the gastric acid barrier and consequently harbors relatively small numbers of bacteria. The small bowel also has a limited microbial community, in part, likely due to its rapid motility and higher oxygen content that limit stable anaerobic bacterial colonization. In contrast, if this flow is disrupted (eg, stagnant small bowel segment due to stricture, obstruction, diverticulum, blind loop), high concentrations of bacteria result with a predominance of anaerobes [
         <a href="#rid61">
          61
         </a>
         ]. This bacterial overgrowth pattern may cause malabsorption (see
         <a class="medical medical_review" href="/z/d/html/4783.html" rel="external">
          "Small intestinal bacterial overgrowth: Etiology and pathogenesis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2629.html" rel="external">
          "Pathophysiology of irritable bowel syndrome", section on 'Alteration in fecal microflora'
         </a>
         ). The largest concentrations of anaerobic bacteria are found in the relatively stagnant terminal ileum and colon, where concentrations reach 10
         <sup>
          11
         </sup>
         per gram, and anaerobic bacteria account for approximately 99.9 percent of the bacteria present [
         <a href="#rid3">
          3,62,63
         </a>
         ]. The most important and frequent anaerobic bacteria are
         <em>
          Bacteroides
         </em>
         spp,
         <em>
          Prevotella
         </em>
         spp,
         <em>
          Clostridium
         </em>
         spp, and
         <em>
          Peptostreptococcus
         </em>
         spp  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
         Intra-abdominal infections are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/101694.html" rel="external">
          "Antimicrobial approach to intra-abdominal infections in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6479.html" rel="external">
          "Acute appendicitis in children: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1386.html" rel="external">
          "Acute appendicitis in adults: Clinical manifestations and differential diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2864321405">
         <span class="h2">
          Infections of the female genital tract
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nearly all infections of the female genital tract that are not caused by sexually transmitted pathogens are likely to involve anaerobic bacteria  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). This includes pyometra (accumulation of pus in the uterine cavity), tubo-ovarian abscess, amnionitis, septic abortion or gynecologic procedures, endometritis, septic pelvic thrombophlebitis, and some wound infections after gynecologic surgery. Pelvic inflammatory disease (PID) is most often an ascending infection caused by anaerobic and facultative aerobic vaginal bacteria including those causing bacterial vaginosis; less than half of PID cases are associated with sexually transmitted pathogens (eg,
         <em>
          Neisseria gonorrhoeae
         </em>
         ,
         <em>
          Chlamydia trachomatis
         </em>
         ). PID predisposes to infertility [
         <a href="#rid64">
          64-67
         </a>
         ].
        </p>
        <p>
         The most common anaerobes are aerobic, microaerobic, and anaerobic lactobacilli,
         <em>
          Peptostreptococcus
         </em>
         spp,
         <em>
          Bacteroides
         </em>
         spp, and penicillin-resistant anaerobes such as
         <em>
          Prevotella bivia
         </em>
         and
         <em>
          Prevotella disiens
         </em>
         (formerly
         <em>
          Bacteroides bivius and Bacteroides disiens
         </em>
         ). There are emerging associations of
         <em>
          Fusobacterium nucleatum
         </em>
         ,
         <em>
          Porphyromonas gingivalis
         </em>
         , and
         <em>
          Sneathia
         </em>
         infections with pregnancy and adverse outcomes of pregnancy [
         <a href="#rid68">
          68-70
         </a>
         ]. Factors that appear to influence the bacteriologic findings in the genital tract include menarche, menopause, pregnancy, antibiotic therapy, new sexual partners, male circumcision, hormonal therapy, black race, douching, smoking, and lubricant use [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         The contribution of the genital tract microbiota to homeostasis and disease (eg, susceptibility to sexually transmitted pathogens) and approaches to modifying the genital tract microbiota are under study [
         <a href="#rid71">
          71
         </a>
         ]. Bacterial vaginosis (BV) is a complex dysbiosis of the genital tract flora, with a decrease in lactobacilli concentrations and a predominance of anaerobes [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
         Female genital tract infections are discussed in more detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5451.html" rel="external">
          "Bacterial vaginosis: Clinical manifestations and diagnosis", section on 'Pathogenesis and microbiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3312.html" rel="external">
          "Vulvar abscess", section on 'Microbiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7580.html" rel="external">
          "Pelvic inflammatory disease: Pathogenesis, microbiology, and risk factors"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7589.html" rel="external">
          "Epidemiology, clinical manifestations, and diagnosis of tubo-ovarian abscess", section on 'Microbiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6762.html" rel="external">
          "Clinical chorioamnionitis", section on 'Microbiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/130878.html" rel="external">
          "Septic abortion: Clinical presentation and management", section on 'Epidemiology and microbiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5488.html" rel="external">
          "Postpartum endometritis", section on 'Microbiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2130.html" rel="external">
          "Septic pelvic thrombophlebitis", section on 'Microbiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3289.html" rel="external">
          "Complications of gynecologic surgery", section on 'Infectious morbidity'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3057343347">
         <span class="h2">
          Soft tissue infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic bacteria are common pathogens in a diverse array of skin and soft tissue infections, such as infected sebaceous (epidermal) cysts, infected pilonidal cysts, paronychia, wound infections after surgery, bite wounds, diabetic foot ulcers, and decubitus ulcers [
         <a href="#rid39">
          39,73-79
         </a>
         ]. While
         <em>
          Staphylococcus aureus
         </em>
         and
         <em>
          Streptococcus pyogenes
         </em>
         are commonly viewed as the dominant pathogens in soft tissue infections, anaerobic bacteria account for a major portion of some cutaneous abscesses (eg, pilonidal cysts, bite wounds, diabetic foot infections) and may be playing an important role in hidradenitis suppurativa [
         <a href="#rid80">
          80
         </a>
         ].
        </p>
        <p>
         The skin flora contains large numbers of anaerobic bacteria. The predominant organisms are
         <em>
          Cutibacterium
         </em>
         (formerly
         <em>
          Propionibacterium
         </em>
         )
         <em>
          acnes
         </em>
         and, to a lesser extent, other species of
         <em>
          Cutibacterium
         </em>
         spp and
         <em>
          Peptostreptococcus
         </em>
         spp [
         <a href="#rid81">
          81
         </a>
         ]. Most infections involve the cutaneous or adjacent mucosal surface flora  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ).
         <em>
          Cutibacterium
         </em>
         is occasionally identified in infections involving prosthetic devices, especially shoulder devices [
         <a href="#rid9">
          9,82,83
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5573.html" rel="external">
          "Overview of benign lesions of the skin", section on 'Epidermoid cyst'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/87056.html" rel="external">
          "Pilonidal disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5574.html" rel="external">
          "Paronychia", section on 'Infectious agents'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/120681.html" rel="external">
          "Overview of the evaluation and management of surgical site infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8175.html" rel="external">
          "Management of diabetic foot ulcers", section on 'Managing infection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7657.html" rel="external">
          "Infectious complications of pressure-induced skin and soft tissue injury", section on 'Microbiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H463699133">
         <span class="h3">
          Deep soft tissue infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Deep soft tissue infections likely to involve anaerobic bacteria include necrotizing fasciitis, synergistic necrotizing cellulitis, crepitant cellulitis, and gas gangrene. These infections involve the fascia, the muscle compartment formed by the enveloping fascia, or both. A relatively common feature of these infections is the low oxygen tension in tissues due to poor vascular supply; conditions in which this occurs include diabetes mellitus, injury (including surgery), and trauma. Major pathogens in these deep infections include group A beta-hemolytic streptococci, Clostridia, and combinations of aerobic and anaerobic bacteria [
         <a href="#rid73">
          73,76,84,85
         </a>
         ]  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/7662.html" rel="external">
          "Necrotizing soft tissue infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7672.html" rel="external">
          "Clostridial myonecrosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2433919949">
         <span class="h3">
          Human and animal bites
         </span>
         <span class="headingEndMark">
          —
         </span>
         Human bites, and to a lesser extent animal bites, often involve anaerobic bacteria  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). These types of infections can arise from the oral flora of the biter or from the flora of the adjacent skin of the bite recipient. The clenched fist injury is the equivalent of a human bite in the sense that the infection involves the flora of the mouth of the person struck or the skin flora of the person delivering the punch [
         <a href="#rid79">
          79
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7674.html" rel="external">
          "Human bites: Evaluation and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7671.html" rel="external">
          "Animal bites (dogs, cats, and other mammals): Evaluation and management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2470308500">
         <span class="h2">
          Central nervous system infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pyogenic intracranial infections that commonly involve anaerobic bacteria include cerebral, epidural, and subdural abscess [
         <a href="#rid86">
          86,87
         </a>
         ]. The majority of brain abscesses are polymicrobial (eg, aerobic, anaerobic and/or facultative streptococci, staphylococcal species, other anaerobes, gram-negative rods) and the microbiology depends on the primary source for the infection (eg, complication of sinusitis, hematogenous, post-neurosurgery)  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). Isolation of
         <em>
          Streptococcus anginosus
         </em>
         (also known as
         <em>
          Streptococcus milleri
         </em>
         ) suggests likely bacteremia with disseminated abscess formation [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p>
         Since meningitis rarely involves anaerobes, growth of these bacteria in cerebrospinal fluid (CSF) cultures suggests a parameningeal collection, shunt infection, or contamination. (See
         <a class="medical medical_review" href="/z/d/html/1297.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of brain abscess"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1286.html" rel="external">
          "Infections of cerebrospinal fluid shunts"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/103898.html" rel="external">
          "Intracranial epidural abscess"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2716611822">
         <span class="h2">
          Bacteremia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Over time, anaerobes have accounted for about two to six percent of blood culture isolates from patients with clinically significant bacteremia. Actual frequency of detecting anaerobic bacteremia has differed geographically (eg, &lt;0.5 to 10 percent), potentially related to the patient populations, underlying comorbidities, and local ability to isolate and identify anaerobes from blood cultures [
         <a href="#rid6">
          6,89-91
         </a>
         ]. The value of anaerobic blood cultures has long been debated based on lower microbial yield and the idea that clinical suspicion for anaerobic infections was accurate. However, available data refute both these points and we continue to obtain anaerobic cultures as part of routine blood cultures [
         <a href="#rid89">
          89,92,93
         </a>
         ]. The
         <em>
          B. fragilis
         </em>
         group, Clostridia, and anaerobic cocci are the most common isolates with typically
         <em>
          B. fragilis
         </em>
         sensu stricto considered to be the most common anaerobic bacterium isolated from blood culture specimens [
         <a href="#rid5">
          5-7,94
         </a>
         ]  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). Anaerobic bacteremia crude mortality can be as high as approximately 25 percent, dictated by comorbidities, presence of sepsis, and/or adequacy of source control [
         <a href="#rid89">
          89,94
         </a>
         ]. Isolated bacteremia is rare and should prompt further evaluation for the site of infection. Endocarditis caused by anaerobic bacteria is extremely rare and echocardiograms are generally not warranted in cases of isolated anaerobic bacteremia, except in cases of high suspicion (eg, persistent bacteremia despite appropriate therapy).
         <em>
          Eggerthella lenta
         </em>
         is a recognized cause of anaerobic bacteremia associated with intra-abdominal infections, resistance to
         <a class="drug drug_general" data-topicid="9777" href="/z/d/drug information/9777.html" rel="external">
          piperacillin-tazobactam
         </a>
         , and increased mortality [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         Although anaerobic bacteremia accounts for a small percent of clinically significant bacteremia,
         <em>
          B. fragilis
         </em>
         sensu stricto and
         <em>
          B. fragilis
         </em>
         group bacteremia contributes significantly to morbidity and mortality [
         <a href="#rid7">
          7,94,95
         </a>
         ]. As an example, a case-control study matched patients with
         <em>
          B. fragilis
         </em>
         group bacteremia to control patients without bacteremia but with the same principal diagnosis or the same major surgical procedure [
         <a href="#rid94">
          94
         </a>
         ]. Patients with
         <em>
          B. fragilis
         </em>
         group bacteremia had a significantly higher mortality rate compared with non-bacteremic patients (28 versus 9 percent; attributable mortality rate of 19 percent). Further, a prospective multicenter, observational study confirmed high mortality associated with
         <em>
          Bacteroides
         </em>
         bacteremia especially if inactive therapy was administered (45 versus 16 percent, inactive versus active therapy, p = 0.04) [
         <a href="#rid7">
          7
         </a>
         ]. In this report, antimicrobial susceptibility reliably predicted outcome of
         <em>
          Bacteroides
         </em>
         bacteremia.
        </p>
        <p class="headingAnchor" id="H2260023864">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H5084887">
         <span class="h2">
          When to suspect an anaerobic infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic infections should be suspected if any of the following clinical clues are present  (
         <a class="graphic graphic_table graphicRef58669" href="/z/d/graphic/58669.html" rel="external">
          table 3
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Putrid drainage from wound
         </strong>
         – Putrid odor of wound discharge is considered diagnostic of anaerobic infection. However, it may be a relatively late feature and is only seen in approximately one-third to one half of patients [
         <a href="#rid96">
          96,97
         </a>
         ]. The chemical basis for the odor is not well established, but it presumably reflects the metabolic products of anaerobic bacteria.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Polymicrobial flora on Gram stain
         </strong>
         – Anaerobic infections often involve polymicrobial flora, so a Gram stain with multiple different morphotypes should raise suspicion for an anaerobic infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infection adjacent to mucosal surfaces that normally harbor anaerobic flora
         </strong>
         – Infections involving the upper respiratory tract, gastrointestinal tract, or the female genital tract often include anaerobes  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Role in the human microbiome'
         </a>
         above and
         <a class="local">
          'Sites of infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Presence of abscess, gas, or tissue necrosis
         </strong>
         – Anaerobes are often associated with tissue necrosis and abscess formation. They are frequently isolated from abscesses at virtually all anatomic sites, including cerebral, dental, peritonsillar, lung, intra-abdominal, tubo-ovarian, prostatic, and some cutaneous abscesses. Gas in the tissue is another clue to the presence of anaerobic bacteria, but it is not considered diagnostic because some aerobic bacteria also produce gas (eg,
         <em>
          Streptococcus
         </em>
         <em>
          pyogenes
         </em>
         ) [
         <a href="#rid37">
          37
         </a>
         ]. In addition, gas detected by radiography or scanning techniques may also be due to air introduced during irrigations or other manipulations, such as the release of carbon dioxide or oxygen with hydrogen peroxide.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Classic features of toxin-mediated and/or tissue destructive clostridial syndromes
         </strong>
         – Toxin-mediated and/or tissue destructive clostridial syndromes include tetanus, botulism,
         <em>
          Clostridium perfringens
         </em>
         food poisoning, gas gangrene,
         <em>
          Clostridioides
         </em>
         <em>
          difficile-
         </em>
         induced diarrhea or colitis, and enteritis necroticans. Clostridial species are also known to produce a "leukemoid reaction" causing a markedly elevated white blood cell (WBC) count. Clinical features consistent with any of these syndromes or a marked leukocytosis (WBC &gt;30,000 cells/microL) should prompt suspicion for a Clostridial infection. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         If anaerobes are suspected, empiric therapy against anaerobes should be administered given the difficulty of identifying and isolating anaerobes on culture  (
         <a class="graphic graphic_table graphicRef73450" href="/z/d/graphic/73450.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="local">
          'Antimicrobial therapy'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1866397867">
         <span class="h2">
          Microbiologic diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microbiologic diagnosis of anaerobic bacteria is difficult due to a variety of reasons. Since anaerobic bacteria are part of normal human flora at virtually all anatomic sites, it is often problematic to determine when these bacteria represent true pathogens or merely commensals. Determining whether an anaerobe is a true pathogen is based on the recovered anaerobe, its known pathogenic potential, dominance of anaerobes in the sample, and the specimen source. For example,
         <em>
          B. fragilis
         </em>
         is known to cause life-threatening infections and should be considered a pathogen in the appropriate clinical setting (eg, abscess) but is also a frequent, low abundance member of the colon microbiota in healthy individuals.
        </p>
        <p>
         Optimal clinical specimens for anaerobic culture are normally sterile body fluids or tissue specimens from sterile sites. Swab specimens should be avoided [
         <a href="#rid1">
          1,81,98
         </a>
         ]. However, the presence of anaerobic normal flora on many mucosal sites makes obtaining a sterile specimen difficult. Using anaerobic transport media, maintaining specimens at room temperature (which helps to preserve anaerobe viability better than refrigeration), collecting samples prior to antibiotic administration, and rapidly transporting the samples to the laboratory all assist in anaerobe isolation. In certain circumstances, using techniques that allow acquisition of a more sterile specimen can be helpful to reduce the risk of contamination (eg, culdocentesis, laparoscopy).
        </p>
        <p>
         Another obstacle to microbiologic diagnosis is the fastidious growth characteristics of anaerobes, making these organisms difficult to grow in clinical microbiology laboratories. Gram stain of exudate can provide important clues to the presence of anaerobic bacteria. Anaerobes vary in size and shape and are often pleomorphic. The Gram stain may show morphologic features suggestive of anaerobes, such as
         <em>
          Bacteroides
         </em>
         spp (small, delicate gram-negative bacilli),
         <em>
          Fusobacterium
         </em>
         <em>
          nucleatum
         </em>
         (pleomorphic fusiform bacteria with pointed ends),
         <em>
          Fusobacterium necrophorum
         </em>
         (long, "ropy" gram-negative bacilli), and Clostridia (large "box car"-like gram-positive bacilli). By contrast,
         <em>
          Peptostreptococcus
         </em>
         spp cannot be distinguished from aerobic gram-positive cocci by Gram stain appearance. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H2108385380">
         <span class="h1">
          TREATMENT
         </span>
        </p>
        <p class="headingAnchor" id="H771773206">
         <span class="h2">
          Antimicrobial therapy
         </span>
        </p>
        <p class="headingAnchor" id="H1582110350">
         <span class="h3">
          Rationale for empiric treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most anaerobic infections are treated empirically, since the process of recovery and in vitro
         <em>
         </em>
         testing is often delayed and limited in availability. Empiric therapy is generally effective when chosen based on knowledge of the bacteriology at the apparent source of the infection (eg, colonic perforation, ascending infection from the vagina such as PID, extension of infection from the sinus to the CNS) and the understanding of strain- and geography-dependent antimicrobial resistance patterns among anaerobic bacteria  (
         <a class="graphic graphic_table graphicRef73450" href="/z/d/graphic/73450.html" rel="external">
          table 4
         </a>
         and
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid1">
          1,99
         </a>
         ] (see
         <a class="local">
          'Sites of infection'
         </a>
         above).
        </p>
        <p class="headingAnchor" id="H3694014757">
         <span class="h3">
          Antibiotic selection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Effective antibiotics against anaerobic infections are important to optimize the patient's morbidity and mortality [
         <a href="#rid7">
          7,100,101
         </a>
         ]. Management of mixed aerobe/anaerobic infections requires administration of antimicrobial agents active against each component of the infection.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preferred antibiotics
         </strong>
         – The following (classes of) antibiotics are the most active antibiotics against most anaerobic bacteria (including
         <em>
          B. fragilis
         </em>
         ) and are preferred for the treatment of anaerobic infections  (
         <a class="graphic graphic_table graphicRef73450" href="/z/d/graphic/73450.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid10">
          10,11,99,102
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          Metronidazole
         </a>
         (very effective against gram-negative anaerobic bacteria and less reliable against gram-positive anaerobic bacteria)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Beta-lactam-beta-lactamase inhibitor combinations (amoxicillin-clavulanic acid,
         <a class="drug drug_general" data-topicid="8745" href="/z/d/drug information/8745.html" rel="external">
          ampicillin-sulbactam
         </a>
         ,
         <a class="drug drug_general" data-topicid="9777" href="/z/d/drug information/9777.html" rel="external">
          piperacillin-tazobactam
         </a>
         ,
         <a class="drug drug_general" data-topicid="114672" href="/z/d/drug information/114672.html" rel="external">
          meropenem-vaborbactam
         </a>
         ,
         <a class="drug drug_general" data-topicid="121885" href="/z/d/drug information/121885.html" rel="external">
          imipenem-cilastatin-relebactam
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Carbapenems
        </p>
        <p>
        </p>
        <p>
         Both beta-lactam-beta-lactamase inhibitor combinations and carbapenems are very effective against both gram-positive and gram-negative anaerobic bacteria. However,
         <a class="drug drug_general" data-topicid="100152" href="/z/d/drug information/100152.html" rel="external">
          ceftazidime-avibactam
         </a>
         and
         <a class="drug drug_general" data-topicid="98763" href="/z/d/drug information/98763.html" rel="external">
          ceftolozane-tazobactam
         </a>
         <strong>
          do not
         </strong>
         have activity against many anaerobes, including
         <em>
          B. fragilis
         </em>
         and should not be used for the treatment of anaerobic infections.
        </p>
        <p>
         The management of anaerobic infections for given infectious syndromes is discussed separately in the specific topic for each infectious syndrome.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antibiotics with limited activity
         </strong>
         – While
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         and
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         retain some activity against oral anaerobes, neither antibiotic is sufficiently effective in serious infections. When used, they should be used with caution given the varied susceptibility patterns.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Overall, penicillins, cephalosporins, and macrolides show limited activity against anaerobes due to widespread resistance and should not be used to empirically treat anaerobic infections. Up to 51 percent of all anaerobic bacteria isolated in bloodstream infections have been reported as resistant to penicillin including 20 percent
         <em>
          of Clostridia
         </em>
         species and 10 percent of gram-positive anaerobic cocci [
         <a href="#rid103">
          103
         </a>
         ]. General in vitro susceptibility patterns of various antibiotics against anaerobes are summarized in the table  (
         <a class="graphic graphic_table graphicRef73450" href="/z/d/graphic/73450.html" rel="external">
          table 4
         </a>
         ). Multidrug resistance in anaerobes can occur [
         <a href="#rid101">
          101,104-106
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The most important factor for the clinician to consider when initiating antibiotic therapy of anaerobes is the possibility of antibiotic resistance. (See
         <a class="local">
          'Antimicrobial resistance'
         </a>
         below.)
        </p>
        <p>
         Many factors impact antibiotic resistance including local (hospital) and regional geography (country), antibiotic use patterns, site of infection and even the exact anaerobic species, although the latter will not be available at the time of empiric initiation of antibiotic therapy. Approaches to infection control and antimicrobial and diagnostic stewardship within hospitals can also impact the prevalence of anaerobic antimicrobial resistance. However, because local information may be limited, empiric antibiotic selection for treatment of anaerobic infections is often based on susceptibility test results from sentinel laboratories. If local rates of antimicrobial resistance are available, this information should guide clinicians in empiric antibiotic selection (see
         <a class="local">
          'Antimicrobial resistance'
         </a>
         below). Anticipated anaerobic pathogens for each site of infection are discussed elsewhere. (See
         <a class="local">
          'Sites of infection'
         </a>
         above.)
        </p>
        <p>
         Other considerations for the clinician in selection of empiric antibiotic therapy for anaerobic infections include the preferred mode of administration (intravenous versus oral) for the clinical context and the location of the anaerobic infection (ie, specific site of infection). Although 'above versus below the diaphragm' is a classic construct in considering the selection of antimicrobial agents to treat anaerobic infections, the increasing resistance of oral anaerobes and
         <em>
          B. fragilis
         </em>
         group bacteria to antibiotics now limit its clinical usefulness.
        </p>
        <p>
         Despite the difficulties of in vitro testing as described above, a clear correlation has been noted between antimicrobial in vitro activity and patient survival after treatment for monomicrobial and polymicrobial anaerobic bacteremia or tissue site infections [
         <a href="#rid7">
          7,100,101
         </a>
         ]. This was illustrated, for example, in a prospective observational study of 128 patients with
         <em>
          Bacteroides
         </em>
         spp bacteremia [
         <a href="#rid7">
          7
         </a>
         ]. The mortality rate, clinical failure, and microbiologic persistence by in vitro testing was higher among patients who received inactive therapy than in patients who received active therapy (mortality: 45 versus 16 percent; clinical failure: 82 versus 42 percent; microbiologic persistence: 22 versus 12 percent). (See
         <a class="local">
          'Antimicrobial therapy'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H771773229">
         <span class="h3">
          Antimicrobial resistance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antibiotic resistance among anaerobic bacteria varies widely among different geographic regions and institutions, but is increasing worldwide  (
         <a class="graphic graphic_table graphicRef73450" href="/z/d/graphic/73450.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid10">
          10,107-113
         </a>
         ].
        </p>
        <p>
         Multiple mechanisms of antimicrobial resistance exist in anaerobes including efflux pumps, porin loss,
         <em>
          nim
         </em>
         genes (especially important to
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         resistance in
         <em>
          B. fragilis
         </em>
         group organisms but also associated with resistance to other antibiotics) and other antimicrobial resistance genes (eg,
         <em>
          cfiA
         </em>
         [carbapenem],
         <em>
          cepA/cfxA
         </em>
         [beta-lactams],
         <em>
          ermF
         </em>
         [macrolide-lincosamide-streptogramin],
         <em>
          tetQ
         </em>
         [
         <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">
          tetracycline
         </a>
         ],
         <em>
          gyrA/gyrB/parC
         </em>
         [fluoroquinolone]). These antimicrobial resistance genes mediate production of beta-lactamases, drug degradation, and 23S rRNA methylation as well as decrease affinity of antibiotics for bacterial target molecules. There are other mechanisms of antimicrobial resistance, but they still lack molecular definition. Both chromosomal and transferable plasmid-mediated resistance occur in anaerobes.
        </p>
        <p>
         <em>
          Bacteroides
         </em>
         group members, and especially
         <em>
          B. fragilis
         </em>
         , are the most common anaerobes isolated from human infections and are more likely to be resistant to commonly used antimicrobial agents. Over time, the most significant changes have been with major reductions in the in vitro activity of beta-lactams (eg, penicillins,
         <a class="drug drug_general" data-topicid="9223" href="/z/d/drug information/9223.html" rel="external">
          cefoxitin
         </a>
         ,
         <a class="drug drug_general" data-topicid="9222" href="/z/d/drug information/9222.html" rel="external">
          cefotetan
         </a>
         ),
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         , and
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         against
         <em>
          Bacteroides
         </em>
         group members (especially
         <em>
          B. fragilis
         </em>
         ). In contrast, resistance to
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         , beta-lactam-beta-lactamase inhibitor combinations, and carbapenems remains infrequent in most of the world.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clindamycin
         </strong>
         <strong>
         </strong>
         –
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          Clindamycin
         </a>
         was once a preferred antimicrobial agent for anaerobic infections but resistance can approach 60 percent (range 20 to 60 percent) across the globe inclusive of
         <em>
          B. fragilis
         </em>
         and
         <em>
          B. fragilis
         </em>
         group strains [
         <a href="#rid10">
          10,108,109,111,112
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Moxifloxacin
         </strong>
         – Resistance to
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         , the only fluoroquinolone with predicted anti-anaerobic activity, is now substantial (approximately 20 to 60 percent resistant). Thus, use of moxifloxacin alone for therapy of anaerobic infections is not recommended.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Penicillins and cephalosporins
         </strong>
         – Only 40 to 50 percent of all anaerobes remain sensitive to penicillins [
         <a href="#rid103">
          103,112
         </a>
         ] including &lt;3 percent of
         <em>
          B. fragilis
         </em>
         or
         <em>
          B. fragilis
         </em>
         group strains [
         <a href="#rid108">
          108,109,112
         </a>
         ]. In contrast, beta-lactam beta-lactamase inhibitors remain effective treatment options for anaerobic infections with &gt;90 percent of all anaerobes tested susceptible [
         <a href="#rid112">
          112
         </a>
         ]. However, susceptibility varies within the
         <em>
          Bacteroides
         </em>
         spp with
         <em>
          B. fragilis
         </em>
         being the most susceptible [
         <a href="#rid10">
          10,108
         </a>
         ].
         <em>
          Parabacteroides
         </em>
         (formerly considered part of the
         <em>
          Bacteroides
         </em>
         group
         <em>
          )
         </em>
         and other
         <em>
          Bacteroides spp
         </em>
         have been reported as only approximately 80 percent susceptible to
         <em>
         </em>
         beta-lactam beta-lactamase inhibitors
         <em>
         </em>
         [
         <a href="#rid112">
          112
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Carbapenems
         </strong>
         – Among beta-lactam agents, the carbapenems exhibit the broadest anaerobic organism coverage [
         <a href="#rid111">
          111
         </a>
         ].
         <a class="drug drug_general" data-topicid="8675" href="/z/d/drug information/8675.html" rel="external">
          Ertapenem
         </a>
         ,
         <a class="drug drug_general" data-topicid="9613" href="/z/d/drug information/9613.html" rel="external">
          meropenem
         </a>
         , and
         <a class="drug drug_general" data-topicid="8553" href="/z/d/drug information/8553.html" rel="external">
          imipenem
         </a>
         are all generally equally active (&gt;95 percent susceptible) against anaerobes including the majority of
         <em>
          B. fragilis
         </em>
         or
         <em>
          B. fragilis
         </em>
         group strains [
         <a href="#rid10">
          10,111,112
         </a>
         ] although some studies have reported higher rates of resistance [
         <a href="#rid111">
          111,112
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Metronidazole
         </strong>
         –
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          Metronidazole
         </a>
         remains one of the most effective agents against anaerobic infections (&gt;90 percent of all anaerobes susceptible) [
         <a href="#rid112">
          112
         </a>
         ] and, in particular, is very effective treatment for gram-negative anaerobic bacteria. In the most recent United States-based multicenter surveillance of antimicrobial resistance among
         <em>
          Bacteroides
         </em>
         and
         <em>
          Parabacteroides
         </em>
         species, no resistance was detected in 779 isolates tested [
         <a href="#rid10">
          10
         </a>
         ]. Surveys in other locales have yielded similar results (99 to 100 percent susceptible) [
         <a href="#rid109">
          109,112
         </a>
         ]. Importantly, while metronidazole resistance is associated with
         <em>
          nim
         </em>
         genes, presence of a
         <em>
          nim
         </em>
         gene does not invariably lead to resistance [
         <a href="#rid10">
          10,108
         </a>
         ]. Nonetheless, metronidazole resistance has been reported in
         <em>
          B. fragilis
         </em>
         and
         <em>
          B. fragilis
         </em>
         group strains [
         <a href="#rid10">
          10,101,104,105,111
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multidrug resistance
         </strong>
         – Multidrug-resistant (MDR
         <em>
          ) B. fragilis h
         </em>
         ave been reported in the United States; the isolates from these cases were resistant to
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         , carbapenems,
         <a class="drug drug_general" data-topicid="9777" href="/z/d/drug information/9777.html" rel="external">
          piperacillin-tazobactam
         </a>
         , and
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         , among other agents [
         <a href="#rid104">
          104,105
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H559444719">
         <span class="h2">
          Adjunctive source control
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anaerobic infections are frequently associated with abscess formation. This feature along with the often polymicrobial makeup (ie, mixed infections with aerobes) of anaerobic infections makes source control (eg, draining pus, debriding necrotic tissue, improving tissue oxygenation) a critical consideration in the clinical approach to anaerobic infections. Antibiotic therapy is often adjunctive to source control in the cure of anaerobic infections [
         <a href="#rid107">
          107,114
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2992278553">
         <span class="h2">
          Duration of therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The duration of therapy is based on a multitude of clinical factors, including severity and site of infection, presence of abscesses, and whether the source of infection has been controlled. Details on duration of therapy for given infectious syndromes are discussed in the specific topic reviews.
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         –
         <strong>
         </strong>
         Anaerobic bacteria are fastidious, slow-growing organisms that require low-oxygen conditions for growth and can be difficult to grow in clinical microbiology laboratories. The major clinically significant anaerobes are summarized in the table  (
         <a class="graphic graphic_table graphicRef61844" href="/z/d/graphic/61844.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sites of infection
         </strong>
         – Anaerobes
         <strong>
         </strong>
         are part of the normal skin, genital, oral, and gastrointestinal tract (especially the colon) flora. Infections often originate due to a break in the mucosal barrier at these sites and spread to other sites contiguously. Infections range from relatively minor skin and oral infections (eg, pharyngitis and gingivitis) to life-threatening invasive infections (eg, bacteremia, distant focal suppurative metastatic infections involving the brain, deep neck space, or muscle and fascia) and are often polymicrobial  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Sites of infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         –
         <strong>
         </strong>
         Clinical features that should prompt suspicion for an anaerobic infection are presented in the table  (
         <a class="graphic graphic_table graphicRef58669" href="/z/d/graphic/58669.html" rel="external">
          table 3
         </a>
         ). Most clinical laboratories are able to identify the most clinically important anaerobes  (
         <a class="graphic graphic_table graphicRef61844" href="/z/d/graphic/61844.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'When to suspect an anaerobic infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Empiric therapy
         </strong>
         –
         <strong>
         </strong>
         If anaerobes are suspected, empiric therapy against anaerobes known to cause infection at the apparent source of infection should be administered given the difficulty of identifying and isolating anaerobes on culture  (
         <a class="graphic graphic_table graphicRef141905" href="/z/d/graphic/141905.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Rationale for empiric treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Antimicrobial therapy
         </strong>
         – General in vitro susceptibility patterns of various antibiotics against anaerobes are summarized in the table  (
         <a class="graphic graphic_table graphicRef73450" href="/z/d/graphic/73450.html" rel="external">
          table 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Effective
         </strong>
         –
         <strong>
         </strong>
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          Metronidazole
         </a>
         , beta-lactam-beta-lactamase inhibitor combinations, and carbapenems are the most active antibiotics against
         <em>
          B. fragilis
         </em>
         as well as most other anaerobic bacteria, based on susceptibility test results from sentinel laboratories  (
         <a class="graphic graphic_table graphicRef73450" href="/z/d/graphic/73450.html" rel="external">
          table 4
         </a>
         ).
         <a class="drug drug_general" data-topicid="100152" href="/z/d/drug information/100152.html" rel="external">
          Ceftazidime-avibactam
         </a>
         and
         <a class="drug drug_general" data-topicid="98763" href="/z/d/drug information/98763.html" rel="external">
          ceftolozane-tazobactam
         </a>
         <strong>
          do not
         </strong>
         have activity against many anaerobes, including
         <em>
          B. fragilis,
         </em>
         and should not be used for the treatment of anaerobic infections. (See
         <a class="local">
          'Antibiotic selection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Insufficiently effective
         </strong>
         – While
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         and
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         retain some activity against oral anaerobes, both antibiotics should be used with caution given the varied susceptibility patterns and should be avoided in serious infections  (
         <a class="graphic graphic_table graphicRef73450" href="/z/d/graphic/73450.html" rel="external">
          table 4
         </a>
         ). Penicillins, cephalosporins, and macrolides show limited activity against anaerobes due to widespread resistance. (See
         <a class="local">
          'Antibiotic selection'
         </a>
         above and
         <a class="local">
          'Antimicrobial resistance'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Adjunctive source control
         </strong>
         – Anaerobic infections are frequently associated with abscess formation. This feature along with the often polymicrobial makeup (ie, mixed infections with aerobes) of anaerobic infections makes source control (eg, draining pus, debriding necrotic tissue, improving tissue oxygenation) a critical consideration in the clinical approach to anaerobic infections. (See
         <a class="local">
          'Adjunctive source control'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Duration of antimicrobial therapy
         </strong>
         – The duration of therapy is based on a multitude of clinical factors, including severity and site of infection, presence of abscesses, and whether the source of infection has been controlled. (See
         <a class="local">
          'Duration of therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3039991774">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledge John G Bartlett, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Nagy E, Boyanova L, Justesen US, ESCMID Study Group of Anaerobic Infections. How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories. Clin Microbiol Infect 2018; 24:1139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baughn AD, Malamy MH. The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen. Nature 2004; 427:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007; 20:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polk BF, Kasper DL. Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med 1977; 86:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dumont Y, Bonzon L, Michon AL, et al. Epidemiology and microbiological features of anaerobic bacteremia in two French University hospitals. Anaerobe 2020; 64:102207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen MH, Yu VL, Morris AJ, et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis 2000; 30:870.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ugarte-Torres A, Gillrie MR, Griener TP, Church DL. Eggerthella lenta Bloodstream Infections Are Associated With Increased Mortality Following Empiric Piperacillin-Tazobactam (TZP) Monotherapy: A Population-based Cohort Study. Clin Infect Dis 2018; 67:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Achermann Y, Goldstein EJ, Coenye T, Shirtliff ME. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev 2014; 27:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snydman DR, Jacobus NV, McDermott LA, et al. Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009. Anaerobe 2017; 43:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Copsey-Mawer S, Hughes H, Scotford S, et al. UK Bacteroides species surveillance survey: Change in antimicrobial resistance over 16 years (2000-2016). Anaerobe 2021; 72:102447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition. J Clin Microbiol 2021; 59:e0021321.
          </a>
         </li>
         <li class="breakAll">
          Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Thirtieth Informational Supplement M100-S30. CLSI, Wayne, PA, USA. 2020. http://em100.edaptivedocs.net/dashboard.aspx (Accessed on November 10, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lynch SV, Vercelli D. Microbiota, Epigenetics, and Trained Immunity. Convergent Drivers and Mediators of the Asthma Trajectory from Pregnancy to Childhood. Am J Respir Crit Care Med 2021; 203:802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wensel CR, Pluznick JL, Salzberg SL, Sears CL. Next-generation sequencing: insights to advance clinical investigations of the microbiome. J Clin Invest 2022; 132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med 2016; 375:2369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011; 108 Suppl 1:4554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Queen J, Zhang J, Sears CL. Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and Clostridioides difficile. Gut Microbes 2020; 11:1092.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peled JU, Gomes ALC, Devlin SM, et al. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2020; 382:822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feuerstadt P, Louie TJ, Lashner B, et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med 2022; 386:220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen SH, Louie TJ, Sims M, et al. Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial. JAMA 2022; 328:2062.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kordus SL, Thomas AK, Lacy DB. Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics. Nat Rev Microbiol 2022; 20:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiu R, Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emerg Microbes Infect 2018; 7:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stevens DL, Aldape MJ, Bryant AE. Life-threatening clostridial infections. Anaerobe 2012; 18:254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aldape MJ, Bryant AE, Ma Y, Stevens DL. The leukemoid reaction in Clostridium sordellii infection: neuraminidase induction of promyelocytic cell proliferation. J Infect Dis 2007; 195:1838.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sears CL. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin Microbiol Rev 2009; 22:349.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One 2015; 10:e0119462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boleij A, Hechenbleikner EM, Goodwin AC, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 2015; 60:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15:1016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tzianabos AO, Kasper DL, Onderdonk AB. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin Infect Dis 1995; 20 Suppl 2:S132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krinos CM, Coyne MJ, Weinacht KG, et al. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 2001; 414:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindberg AA, Weintraub A, Zähringer U, Rietschel ET. Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis. Rev Infect Dis 1990; 12 Suppl 2:S133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemierre A. On certain septicaemias. Lancet 1936; 1:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sinave CP, Hardy GJ, Fardy PW. The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection. Medicine (Baltimore) 1989; 68:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García-Bayona L, Coyne MJ, Hantman N, et al. Nanaerobic growth enables direct visualization of dynamic cellular processes in human gut symbionts. Proc Natl Acad Sci U S A 2020; 117:24484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Onderdonk AB, Cisneros RL, Finberg R, et al. Animal model system for studying virulence of and host response to Bacteroides fragilis. Rev Infect Dis 1990; 12 Suppl 2:S169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorbach SL, Mayhew JW, Bartlett JG, et al. Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments. J Clin Invest 1976; 57:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Hee B, Wells JM. Microbial Regulation of Host Physiology by Short-chain Fatty Acids. Trends Microbiol 2021; 29:700.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Louie TJ, Bartlett JG, Tally FP, Gorbach SL. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann Intern Med 1976; 85:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorbach SL, Bartlett JG. Anaerobic infections (second of three parts). N Engl J Med 1974; 290:1237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorbach SL, Bartlett JG. Anaerobic infections (third of three parts). N Engl J Med 1974; 290:1289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gorbach SL, Bartlett JG. Anaerobic infections. 1. N Engl J Med 1974; 290:1177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuriyama T, Williams DW, Yanagisawa M, et al. Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics. Oral Microbiol Immunol 2007; 22:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16 Suppl 4:S248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol 2018; 16:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siqueira JF Jr, Rôças IN. Microbiology and treatment of acute apical abscesses. Clin Microbiol Rev 2013; 26:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammel JM, Fischel J. Dental Emergencies. Emerg Med Clin North Am 2019; 37:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siqueira JF Jr, Rôças IN. Present status and future directions: Microbiology of endodontic infections. Int Endod J 2022; 55 Suppl 3:512.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Craig JR, Cheema AJ, Dunn RT, et al. Extrasinus Complications From Odontogenic Sinusitis: A Systematic Review. Otolaryngol Head Neck Surg 2022; 166:623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farley E, Mehta U, Srour ML, Lenglet A. Noma (cancrum oris): A scoping literature review of a neglected disease (1843 to 2021). PLoS Negl Trop Dis 2021; 15:e0009844.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galli A, Brugger C, Fürst T, et al. Prevalence, incidence, and reported global distribution of noma: a systematic literature review. Lancet Infect Dis 2022; 22:e221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li RM, Kiemeney M. Infections of the Neck. Emerg Med Clin North Am 2019; 37:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bridwell R, Gottlieb M, Koyfman A, Long B. Diagnosis and management of Ludwig's angina: An evidence-based review. Am J Emerg Med 2021; 41:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WS, Jean SS, Chen FL, et al. Lemierre's syndrome: A forgotten and re-emerging infection. J Microbiol Immunol Infect 2020; 53:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karkos PD, Asrani S, Karkos CD, et al. Lemierre's syndrome: A systematic review. Laryngoscope 2009; 119:1552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centor RM, Atkinson TP, Ratliff AE, et al. The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med 2015; 162:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centor RM, Huddle TS. Should the risk of Fusobacterium necrophorum pharyngotonsillitis influence prescribing empiric antibiotics for sore throats in adolescents and young adults? Anaerobe 2021; 71:102388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centor RM, Atkinson TP, Xiao L. Fusobacterium necrophorum oral infections - A need for guidance. Anaerobe 2022; 75:102532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett JG. How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy. Infect Dis Clin North Am 2013; 27:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DiBardino DM, Wunderink RG. Aspiration pneumonia: a review of modern trends. J Crit Care 2015; 30:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol 2020; 115:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore WE, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974; 27:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JY, Tsolis RM, Bäumler AJ. The microbiome and gut homeostasis. Science 2022; 377:eabp9960.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hillier SL, Bernstein KT, Aral S. A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease. J Infect Dis 2021; 224:S23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiesenfeld HC, Meyn LA, Darville T, et al. A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease. Clin Infect Dis 2021; 72:1181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ravel J, Moreno I, Simón C. Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am J Obstet Gynecol 2021; 224:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eschenbach DA, Buchanan TM, Pollock HM, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 1975; 293:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chopra A, Radhakrishnan R, Sharma M. Porphyromonas gingivalis and adverse pregnancy outcomes: a review on its intricate pathogenic mechanisms. Crit Rev Microbiol 2020; 46:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Theis KR, Florova V, Romero R, et al. Sneathia: an emerging pathogen in female reproductive disease and adverse perinatal outcomes. Crit Rev Microbiol 2021; 47:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vander Haar EL, So J, Gyamfi-Bannerman C, Han YW. Fusobacterium nucleatum and adverse pregnancy outcomes: Epidemiological and mechanistic evidence. Anaerobe 2018; 50:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuddenham S, Ravel J, Marrazzo JM. Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections. J Infect Dis 2021; 223:S222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu S, Hugerth LW, Schuppe-Koistinen I, Du J. The right bug in the right place: opportunities for bacterial vaginosis treatment. NPJ Biofilms Microbiomes 2022; 8:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finegold SM, Bartlett JG, Chow AW, et al. Management of anaerobic infections. Ann Intern Med 1975; 83:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wittmann DH, Schein M, Seoane D, et al. Pyoderma fistulans sinifica (fox den disease): a distinctive soft-tissue infection. Clin Infect Dis 1995; 21:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lipsky BA, Senneville É, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev 2020; 36 Suppl 1:e3280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bystritsky R, Chambers H. Cellulitis and Soft Tissue Infections. Ann Intern Med 2018; 168:ITC17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ardelt M, Dittmar Y, Kocijan R, et al. Microbiology of the infected recurrent sacrococcygeal pilonidal sinus. Int Wound J 2016; 13:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leggit JC. Acute and Chronic Paronychia. Am Fam Physician 2017; 96:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greene SE, Fritz SA. Infectious Complications of Bite Injuries. Infect Dis Clin North Am 2021; 35:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guet-Revillet H, Jais JP, Ungeheuer MN, et al. The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study. Clin Infect Dis 2017; 65:282.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Church DL. Selected Topics in Anaerobic Bacteriology. Microbiol Spectr 2016; 4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wouthuyzen-Bakker M, Benito N, Soriano A. The Effect of Preoperative Antimicrobial Prophylaxis on Intraoperative Culture Results in Patients with a Suspected or Confirmed Prosthetic Joint Infection: a Systematic Review. J Clin Microbiol 2017; 55:2765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butler-Wu SM, Burns EM, Pottinger PS, et al. Optimization of periprosthetic culture for diagnosis of Propionibacterium acnes prosthetic joint infection. J Clin Microbiol 2011; 49:2490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stone HH, Martin JD Jr. Synergistic necrotizing cellulitis. Ann Surg 1972; 175:702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elliott D, Kufera JA, Myers RA. The microbiology of necrotizing soft tissue infections. Am J Surg 2000; 179:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology 2014; 82:806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brouwer MC, Tunkel AR, McKhann GM 2nd, van de Beek D. Brain abscess. N Engl J Med 2014; 371:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pilarczyk-Zurek M, Sitkiewicz I, Koziel J. The Clinical View on Streptococcus anginosus Group - Opportunistic Pathogens Coming Out of Hiding. Front Microbiol 2022; 13:956677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vena A, Muñoz P, Alcalá L, et al. Are incidence and epidemiology of anaerobic bacteremia really changing? Eur J Clin Microbiol Infect Dis 2015; 34:1621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE. Reemergence of anaerobic bacteremia. Clin Infect Dis 2007; 44:895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fenner L, Widmer AF, Straub C, Frei R. Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J Clin Microbiol 2008; 46:2432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gross I, Gordon O, Abu Ahmad W, et al. Yield of Anaerobic Blood Cultures in Pediatric Emergency Department Patients. Pediatr Infect Dis J 2018; 37:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ransom EM, Burnham CD. Routine Use of Anaerobic Blood Culture Bottles for Specimens Collected from Adults and Children Enhances Microorganism Recovery and Improves Time to Positivity. J Clin Microbiol 2022; 60:e0050022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Redondo MC, Arbo MD, Grindlinger J, Snydman DR. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin Infect Dis 1995; 20:1492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng CW, Lin HS, Ye JJ, et al. Clinical significance of and outcomes for Bacteroides fragilis bacteremia. J Microbiol Immunol Infect 2009; 42:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altemeier WA. The cause of the putrid odor of perforated appendicitis with peritonitis. Ann Surg 1938; 107:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lorber B. "Bad breath": presenting manifestation of anaerobic pulmonary infection. Am Rev Respir Dis 1975; 112:875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis 2018; 67:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brook I. Spectrum and treatment of anaerobic infections. J Infect Chemother 2016; 22:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zahar JR, Farhat H, Chachaty E, et al. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin Microbiol Infect 2005; 11:724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubreuil L, Veloo AC, Sóki J, ESCMID Study Group for Anaerobic Infections (ESGAI). Correlation between antibiotic resistance and clinical outcome of anaerobic infections; mini-review. Anaerobe 2021; 72:102463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kierzkowska M, Majewska A, Mlynarczyk G. Trends and Impact in Antimicrobial Resistance Among Bacteroides and Parabacteroides Species in 2007-2012 Compared to 2013-2017. Microb Drug Resist 2020; 26:1452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Bella S, Antonello RM, Sanson G, et al. Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey. Anaerobe 2022; 75:102583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Multidrug-resistant bacteroides fragilis--Seattle, Washington, 2013. MMWR Morb Mortal Wkly Rep 2013; 62:694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sherwood JE, Fraser S, Citron DM, et al. Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan. Anaerobe 2011; 17:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyanova L, Kolarov R, Mitov I. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe 2015; 31:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snydman DR, Jacobus NV, McDermott LA, et al. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Clin Infect Dis 2010; 50 Suppl 1:S26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schuetz AN. Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis 2014; 59:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forbes JD, Kus JV, Patel SN. Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019. Anaerobe 2021; 70:102386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooley L, Teng J. Anaerobic resistance: should we be worried? Curr Opin Infect Dis 2019; 32:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jean S, Wallace MJ, Dantas G, Burnham CD. Time for Some Group Therapy: Update on Identification, Antimicrobial Resistance, Taxonomy, and Clinical Significance of the Bacteroides fragilis Group. J Clin Microbiol 2022; 60:e0236120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wybo I, Van den Bossche D, Soetens O, et al. Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 2014; 69:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veloo ACM, Tokman HB, Jean-Pierre H, et al. Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI study. Anaerobe 2020; 61:102111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu CY, Huang YT, Liao CH, et al. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrob Agents Chemother 2008; 52:3161.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5520 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29458156" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : How to isolate, identify and determine antimicrobial susceptibility of anaerobic bacteria in routine laboratories.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14749831" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15831718" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Diversity of the human intestinal microbial flora.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17934076" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Bacteroides: the good, the bad, and the nitty-gritty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/322563" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Bacteroides fragilis subspecies in clinical isolates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32360436" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Epidemiology and microbiological features of anaerobic bacteremia in two French University hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10852736" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29373647" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Eggerthella lenta Bloodstream Infections Are Associated With Increased Mortality Following Empiric Piperacillin-Tazobactam (TZP) Monotherapy: A Population-based Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24982315" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27867083" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Trends in antimicrobial resistance among Bacteroides species and Parabacteroides species in the United States from 2010-2012 with comparison to 2008-2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34560274" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : UK Bacteroides species surveillance survey: Change in antimicrobial resistance over 16 years (2000-2016).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34550809" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34550809" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33493428" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Microbiota, Epigenetics, and Trained Immunity. Convergent Drivers and Mediators of the Asthma Trajectory from Pregnancy to Childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35362479" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Next-generation sequencing: insights to advance clinical investigations of the microbiome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27974040" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The Human Intestinal Microbiome in Health and Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20847294" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32037950" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Oral antibiotic use and chronic disease: long-term health impact beyond antimicrobial resistance and Clostridioides difficile.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32101664" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35045228" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36260754" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Extended Follow-up of Microbiome Therapeutic SER-109 Through 24 Weeks for Recurrent Clostridioides difficile Infection in a Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34837014" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30082713" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : An update on the human and animal enteric pathogen Clostridium perfringens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22120198" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Life-threatening clostridial infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17492600" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : The leukemoid reaction in Clostridium sordellii infection: neuraminidase induction of promyelocytic cell proliferation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19366918" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25751261" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25305284" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19701202" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7548535" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11734857" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Extensive surface diversity of a commensal microorganism by multiple DNA inversions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2406867" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Structure-activity relationships in lipopolysaccharides of Bacteroides fragilis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : On certain septicaemias
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2646510" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32938803" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Nanaerobic growth enables direct visualization of dynamic cellular processes in human gut symbionts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2406869" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Animal model system for studying virulence of and host response to Bacteroides fragilis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1254729" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Rapid diagnosis of anaerobic infections by direct gas-liquid chromatography of clinical speciments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33674141" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Microbial Regulation of Host Physiology by Short-chain Fatty Acids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/970773" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Aerobic and anaerobic bacteria in diabetic foot ulcers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4596718" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Anaerobic infections (second of three parts).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4597253" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Anaerobic infections (third of three parts).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4824012" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Anaerobic infections. 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17600542" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8324127" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Anaerobic bacterial infections of the lung and pleural space.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30301974" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The oral microbiota: dynamic communities and host interactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23554416" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Microbiology and treatment of acute apical abscesses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30454782" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Dental Emergencies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34958494" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Present status and future directions: Microbiology of endodontic infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34253072" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Extrasinus Complications From Odontogenic Sinusitis: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34905547" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Noma (cancrum oris): A scoping literature review of a neglected disease (1843 to 2021).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35303478" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Prevalence, incidence, and reported global distribution of noma: a systematic literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30454783" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Infections of the Neck.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33383265" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Diagnosis and management of Ludwig's angina: An evidence-based review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32303484" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Lemierre's syndrome: A forgotten and re-emerging infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19554637" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Lemierre's syndrome: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25686164" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34089856" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Should the risk of Fusobacterium necrophorum pharyngotonsillitis influence prescribing empiric antibiotics for sore throats in adolescents and young adults?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35122953" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Fusobacterium necrophorum oral infections - A need for guidance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23398871" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25129577" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Aspiration pneumonia: a review of modern trends.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32023228" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4598229" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Human fecal flora: the normal flora of 20 Japanese-Hawaiians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35771903" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : The microbiome and gut homeostasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34396398" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : A Review of the Challenges and Complexities in the Diagnosis, Etiology, Epidemiology, and Pathogenesis of Pelvic Inflammatory Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32052831" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33091407" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/806017" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Polymicrobial etiology of acute pelvic inflammatory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32267781" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Porphyromonas gingivalis and adverse pregnancy outcomes: a review on its intricate pathogenic mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33823747" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Sneathia: an emerging pathogen in female reproductive disease and adverse perinatal outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29409815" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Fusobacterium nucleatum and adverse pregnancy outcomes: Epidemiological and mechanistic evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33576776" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35501321" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : The right bug in the right place: opportunities for bacterial vaginosis treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1190633" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Management of anaerobic infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7578725" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Pyoderma fistulans sinifica (fox den disease): a distinctive soft-tissue infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32176444" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29404597" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Cellulitis and Soft Tissue Infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24758263" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Microbiology of the infected recurrent sacrococcygeal pilonidal sinus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28671378" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Acute and Chronic Paronychia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33494873" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Infectious Complications of Bite Injuries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28379372" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27726792" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Selected Topics in Anaerobic Bacteriology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28659322" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : The Effect of Preoperative Antimicrobial Prophylaxis on Intraoperative Culture Results in Patients with a Suspected or Confirmed Prosthetic Joint Infection: a Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21543562" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Optimization of periprosthetic culture for diagnosis of Propionibacterium acnes prosthetic joint infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4555030" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Synergistic necrotizing cellulitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10930480" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : The microbiology of necrotizing soft tissue infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24477107" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25075836" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Brain abscess.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35898914" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : The Clinical View on Streptococcus anginosus Group - Opportunistic Pathogens Coming Out of Hiding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26017663" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Are incidence and epidemiology of anaerobic bacteremia really changing?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17342637" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Reemergence of anaerobic bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18463219" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28858042" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Yield of Anaerobic Blood Cultures in Pediatric Emergency Department Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36040158" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Routine Use of Anaerobic Blood Culture Bottles for Specimens Collected from Adults and Children Enhances Microorganism Recovery and Improves Time to Positivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7548498" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Attributable mortality of bacteremia associated with the Bacteroides fragilis group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19812858" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Clinical significance of and outcomes for Bacteroides fragilis bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : The cause of the putrid odor of perforated appendicitis with peritonitis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1203000" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : "Bad breath": presenting manifestation of anaerobic pulmonary infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29955859" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26620376" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Spectrum and treatment of anaerobic infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16104987" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34597797" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Correlation between antibiotic resistance and clinical outcome of anaerobic infections; mini-review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32407191" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Trends and Impact in Antimicrobial Resistance Among Bacteroides and Parabacteroides Species in 2007-2012 Compared to 2013-2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35568274" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23985497" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Multidrug-resistant bacteroides fragilis--Seattle, Washington, 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21376821" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24875330" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20067390" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24867792" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Antimicrobial resistance and susceptibility testing of anaerobic bacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34044100" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Antimicrobial susceptibility profiles of invasive isolates of anaerobic bacteria from a large Canadian reference laboratory: 2012-2019.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31567734" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Anaerobic resistance: should we be worried?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35700139" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Time for Some Group Therapy: Update on Identification, Antimicrobial Resistance, Taxonomy, and Clinical Significance of the Bacteroides fragilis Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24008826" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31634565" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18625771" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
